Uptick Partners LLC purchased a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the second quarter, HoldingsChannel reports. The institutional investor purchased 5,834 shares of the company’s stock, valued at approximately $750,000.
A number of other institutional investors have also recently made changes to their positions in MKGAF. Gables Capital Management Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at $2,095,000. Diversify Advisory Services LLC bought a new stake in shares of Merck KGaA during the 2nd quarter worth $3,810,000. Danske Bank A S purchased a new position in Merck KGaA in the second quarter worth $276,535,000. Danica Pension Livsforsikringsaktieselskab purchased a new position in Merck KGaA in the second quarter worth $25,541,000. Finally, BOK Financial Private Wealth Inc. bought a new position in Merck KGaA in the second quarter valued at $523,000. Institutional investors own 0.10% of the company’s stock.
Merck KGaA Trading Up 4.5%
OTCMKTS MKGAF opened at $167.38 on Thursday. The stock’s 50-day simple moving average is $162.50 and its two-hundred day simple moving average is $148.28. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The company has a market capitalization of $21.63 billion, a price-to-earnings ratio of 25.55 and a beta of 0.96.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
